Literature DB >> 31980276

A novel hybrid BCI speller based on RSVP and SSVEP paradigm.

Shayan Jalilpour1, Sepideh Hajipour Sardouie2, Amirmohammad Mijani1.   

Abstract

BACKGROUND AND
OBJECTIVE: Steady-state visual evoked potential (SSVEP) and rapid serial visual presentation (RSVP) are useful methods in the brain-computer interface (BCI) systems. Hybrid BCI systems that combine these two approaches can enhance the proficiency of the P300 spellers.
METHODS: In this study, a new hybrid RSVP/SSVEP BCI is proposed to increase the classification accuracy and information transfer rate (ITR) as compared with the other RSVP speller paradigms. In this paradigm, RSVP (eliciting a P300 response) and SSVEP stimulations are presented in such a way that the target group of characters is identified by RSVP stimuli, and the target character is recognized by SSVEP stimuli.
RESULTS: The proposed paradigm achieved accuracy of 93.06%, and ITR of 23.41 bit/min averaged across six subjects.
CONCLUSIONS: The new hybrid system demonstrates that by using SSVEP stimulation in Triple RSVP speller paradigm, we could enhance the performance of the system as compared with the traditional Triple RSVP paradigm. Our work is the first hybrid paradigm in RSVP spellers that could obtain the higher classification accuracy and information transfer rate in comparison with the previous RSVP spellers.
Copyright © 2020. Published by Elsevier B.V.

Keywords:  Brain computer interface (BCI): Hybrid paradigm: Rapid serial visual presentation (RSVP): Steady-state visual evoked potential (SSVEP): P300

Mesh:

Year:  2020        PMID: 31980276     DOI: 10.1016/j.cmpb.2020.105326

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  1 in total

1.  An efficient 3D column-only P300 speller paradigm utilizing few numbers of electrodes and flashings for practical BCI implementation.

Authors:  Onur Erdem Korkmaz; Onder Aydemir; Emin Argun Oral; Ibrahim Yucel Ozbek
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.